Retaglutide is a novel GLP-1 receptor agonist currently under research for the management of metabolic disorders. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://estelledkep093610.p2blogs.com/37503130/semaglutide-a-potential-solution-for-obesity